Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, LIPÍDEOS
ABNT
ANDERSON, Jacqueline et al. Effects PCSK9 polymorphisms on serum lipids in response to atorvastatin in brazilian population. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 07 ago. 2024. , 2010APA
Anderson, J., Cerda, Á., Hirata, M. H., & Hirata, R. D. C. (2010). Effects PCSK9 polymorphisms on serum lipids in response to atorvastatin in brazilian population. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Anderson J, Cerda Á, Hirata MH, Hirata RDC. Effects PCSK9 polymorphisms on serum lipids in response to atorvastatin in brazilian population. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 83 res. FCF162.[citado 2024 ago. 07 ]Vancouver
Anderson J, Cerda Á, Hirata MH, Hirata RDC. Effects PCSK9 polymorphisms on serum lipids in response to atorvastatin in brazilian population. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 83 res. FCF162.[citado 2024 ago. 07 ]